Sodium and chloride ion transporters and channels (None universally; frequently used abbreviations for specific proteins include "ENaC" (epithelial sodium channel), "NCC" (sodium-chloride co-transporter), "CFTR" (cystic fibrosis transmembrane conductance regulator), "ClC" (chloride channel family), etc.)

Sodium and chloride ion transporters and channels are integral membrane proteins responsible for the movement of sodium (Na⁺) and chloride (Cl⁻) ions across biological membranes. Ion channels allow passive movement of these ions, often tightly regulated by voltage, ligands, or mechanical forces, critical in generating action potentials, maintaining membrane potential, and regulating fluid and electrolyte balance. Transporters enable active or coupled transport, facilitating reabsorption and secretion of ions in various tissues (notably kidney, lung, and neurons). Dysfunction of sodium and chloride channels or transporters is directly implicated in a range of diseases (channelopathies) including cystic fibrosis, epilepsy, hypertension, and muscle disorders. Pharmacological agents targeting these proteins are widely used in clinical practice, but off-target activity and channel/transport specificity pose safety and therapeutic challenges.

Other names

Sodium channelChloride channelSodium transporterChloride transporterENaCNCCCFTRClCSLC26 familyChannelrhodopsin (for anion-conducting forms)

Drugs targeting these proteins can act via channel blockade (inhibiting ion flow, e.g., antiarrhythmics, local anesthetics), potentiation (increasing channel opening, e.g., CFTR potentiators), modulation (through gating or phosphorylation), or inhibition of transporter function (competitive or allosteric, e.g., diuretics).